Monlunabant is an investigational inverse agonist of the CB1 receptor which plays an important role in metabolism and appetite regulation in the central nervous system as well as in peripheral tissues such as adipose tissues, the gastrointestinal tract, kidneys, liver, pancreas, muscles and lungs
Human safety data is insufficient to make any definitive statement about long-term use, with no large-scale toxicology or long-term safety trials in humans performed as of this writing
An explanation for this discrepancy was suggested by the differences in SNAP-GLP-1R recycling, reduced with exendin-asp3 vs
It plays a crucial role in maintaining cellular health, protecting against oxidative stress, and regulating melanin production
The transition timeline from tirzepatide can help you plan for this adjustment period